Search research articles
Contact Us
Filters
Showing results (151-160 of 156) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 156 results.
Nature Communications
|
November 12, 2020
Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19
Shidan Tosif, Melanie R Neeland, Philip Sutton, et al.
Cell Reports
|
October 5, 2021
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain
Adam K Wheatley, Phillip Pymm, Robyn Esterbauer, et al.
The Lancet. Infectious Diseases
|
April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Zheyi Li, et al.
Nature Communications
|
April 2, 2021
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
Kevin J Selva, Carolien E van de Sandt, Melissa M Lemke, et al.
Nature Communications
|
May 19, 2022
SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity
Wuji Zhang, Brendon Y Chua, Kevin J Selva, et al.
JCI Insight
|
April 10, 2023
Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations
Jennifer R Habel, Brendon Y Chua, Lukasz Kedzierski, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 156) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 156 results.
Nature Communications
|
November 12, 2020
Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19
Shidan Tosif, Melanie R Neeland, Philip Sutton, et al.
Cell Reports
|
October 5, 2021
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain
Adam K Wheatley, Phillip Pymm, Robyn Esterbauer, et al.
The Lancet. Infectious Diseases
|
April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Zheyi Li, et al.
Nature Communications
|
April 2, 2021
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
Kevin J Selva, Carolien E van de Sandt, Melissa M Lemke, et al.
Nature Communications
|
May 19, 2022
SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity
Wuji Zhang, Brendon Y Chua, Kevin J Selva, et al.
JCI Insight
|
April 10, 2023
Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations
Jennifer R Habel, Brendon Y Chua, Lukasz Kedzierski, et al.
Page
of 16